🔎 Trials Near Me

Akèy › Limfòm Burkitt › New Jersey

Etid klinik pou Limfòm Burkitt nan New Jersey

8 etid pou Limfòm Burkitt ap chèche patisipan nan sit nan New Jersey.

Vil nan New Jersey

Tèks ofisyèl etid la (Anglè)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • Hackensack University Medical Center, Hackensack
  • Morristown Medical Center, Morristown
  • Jersey Shore Medical Center, Neptune City
  • ak 2 plis
Ap rekriteFaz 2
366 Days – 46 Years · Tout sèks · Mizajou Oct 2, 2026 · NCT06124157

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Hackensack University Medical Center, Hackensack
  • Morristown Medical Center, Morristown
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick
  • ak 1 plis
Ap rekriteFaz 2
365 Days · Tout sèks · Mizajou Sep 25, 2026 · NCT06317662

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

  • Hackensack Meridian Health, Hackensack
  • Carol G Simon Cancer Center, Morristown
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07648264

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  • Rutgers Cancer Institute of New Jersey ( Site 1008), New Brunswick
Ap rekriteFaz 1/2
6 Months – 25 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  • Hackensack University Medical Center, Hackensack
  • Morristown Medical Center, Morristown
  • Saint Peter's University Hospital, New Brunswick
  • ak 4 plis
Ap rekriteFaz 2
Laj 1 a 30 · Tout sèks · Mizajou Sep 1, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Hackensack University Medical Center, Hackensack
  • Morristown Medical Center, Morristown
  • Jersey Shore Medical Center, Neptune City
  • ak 4 plis
Ap rekriteFaz 3
365 Days – 25 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03959085

Study of SGR-1505 in Mature B-Cell Neoplasms

  • Regional Cancer Care Associates, Hackensack
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT05544019

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • Hackensack University Medical Center, Hackensack
Ap rekriteFaz 2
Laj 1 a 25 · Tout sèks · Mizajou May 4, 2025 · NCT03509961

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.